151 related articles for article (PubMed ID: 29885251)
1. Serious Hypoglycemia and Use of Warfarin in Combination With Sulfonylureas or Metformin.
Nam YH; Brensinger CM; Bilker WB; Leonard CE; Han X; Hennessy S
Clin Pharmacol Ther; 2019 Jan; 105(1):210-218. PubMed ID: 29885251
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylureas and Metformin Were Not Associated With an Increased Rate of Serious Bleeding in Warfarin Users: A Self-Controlled Case Series Study.
Nam YH; Han X; Brensinger CM; Bilker WB; Leonard CE; Hennessy S
Clin Pharmacol Ther; 2020 Nov; 108(5):1010-1017. PubMed ID: 32392373
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-Converting Enzyme Inhibitors Used Concomitantly with Insulin Secretagogues and the Risk of Serious Hypoglycemia.
Hee Nam Y; Brensinger CM; Bilker WB; Flory JH; Leonard CE; Hennessy S
Clin Pharmacol Ther; 2022 Jan; 111(1):218-226. PubMed ID: 34312836
[TBL] [Abstract][Full Text] [Related]
4. Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas.
Bosco-Lévy P; Salvo F
BMJ; 2016 Aug; 354():i4328. PubMed ID: 27495245
[No Abstract] [Full Text] [Related]
5. Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis.
Romley JA; Gong C; Jena AB; Goldman DP; Williams B; Peters A
BMJ; 2015 Dec; 351():h6223. PubMed ID: 26643108
[TBL] [Abstract][Full Text] [Related]
6. Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
Parekh TM; Raji M; Lin YL; Tan A; Kuo YF; Goodwin JS
JAMA Intern Med; 2014 Oct; 174(10):1605-12. PubMed ID: 25179404
[TBL] [Abstract][Full Text] [Related]
7. Authors' reply to Bosco-Lévy and Salvo.
Romley JA; Gong C; Jena AB; Goldman DP; Williams B; Peters A
BMJ; 2016 Aug; 354():i4330. PubMed ID: 27496026
[No Abstract] [Full Text] [Related]
8. Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study.
Leonard CE; Han X; Brensinger CM; Bilker WB; Cardillo S; Flory JH; Hennessy S
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):9-18. PubMed ID: 29108130
[TBL] [Abstract][Full Text] [Related]
9. Individual sulfonylureas and serious hypoglycemia in older people.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
J Am Geriatr Soc; 1996 Jul; 44(7):751-5. PubMed ID: 8675920
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
Hermansen K; Kolotkin RL; Hammer M; Zdravkovic M; Matthews D
Prim Care Diabetes; 2010 Jul; 4(2):113-7. PubMed ID: 20444662
[TBL] [Abstract][Full Text] [Related]
11. Hypoglycemia in hospitalized patients treated with sulfonylureas.
Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
[TBL] [Abstract][Full Text] [Related]
12. Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
Leonard CE; Bilker WB; Brensinger CM; Han X; Flory JH; Flockhart DA; Gagne JJ; Cardillo S; Hennessy S
Clin Pharmacol Ther; 2016 May; 99(5):538-47. PubMed ID: 26566262
[TBL] [Abstract][Full Text] [Related]
13. Non-severe Hypoglycemia Risk Difference between Sulfonylurea and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2-I) as an Add-On to Metformin in Randomized Controlled Trials.
Farahani P
J Popul Ther Clin Pharmacol; 2017 May; 24(2):e32-e40. PubMed ID: 28594482
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
15. Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort Study.
Weeda ER; Ward R; Gebregziabher M; Chandler O; Strychalski ML; Axon RN; Taber DJ
Prim Care Diabetes; 2023 Aug; 17(4):386-391. PubMed ID: 37121788
[TBL] [Abstract][Full Text] [Related]
16. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.
Bodmer M; Meier C; Krähenbühl S; Jick SS; Meier CR
Diabetes Care; 2008 Nov; 31(11):2086-91. PubMed ID: 18782901
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas.
Shorr RI; Ray WA; Daugherty JR; Griffin MR
Arch Intern Med; 1997 Aug 11-25; 157(15):1681-6. PubMed ID: 9250229
[TBL] [Abstract][Full Text] [Related]
19. Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study.
Leiter LA; Yoon KH; Arias P; Langslet G; Xie J; Balis DA; Millington D; Vercruysse F; Canovatchel W; Meininger G
Diabetes Care; 2015 Mar; 38(3):355-64. PubMed ID: 25205142
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.
Douros A; Yin H; Yu OHY; Filion KB; Azoulay L; Suissa S
Diabetes Care; 2017 Nov; 40(11):1506-1513. PubMed ID: 28864502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
